MedPath

Magnesium sulfate

Generic Name
Magnesium sulfate
Brand Names
Concept Ob, Suflave, Suprep Bowel Prep Kit, Tis-U-sol
Drug Type
Small Molecule
Chemical Formula
MgO4S
CAS Number
7487-88-9
Unique Ingredient Identifier
ML30MJ2U7I
Background

A small colorless crystal used as an anticonvulsant, a cathartic, and an electrolyte replenisher in the treatment of pre-eclampsia and eclampsia. It causes direct inhibition of action potentials in myometrial muscle cells. Excitation and contraction are uncoupled, which decreases the frequency and force of contractions. (From AMA Drug Evaluations Annual, 1992, p1083)

Indication

Used for immediate control of life-threatening convulsions in the treatment of severe toxemias (pre-eclampsia and eclampsia) of pregnancy and in the treatment of acute nephritis in children. Also indicated for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those of hypocalcemia. Also used in uterine tetany as a myometriat relaxant.

Associated Conditions
Constipation, Convulsions, Hypomagnesemia, Torsades de Pointes, Barium poisoning, Severe Exacerbation of asthma
Associated Therapies
Bowel preparation therapy, Soaking aid for minor sprains and bruises

Magnesium Sulfate and Postoperative Hypercoagulability in Laparoscopic Gynecological Surgeries

Not Applicable
Recruiting
Conditions
Magnesium Sulfate
Thromboelastometry
Interventions
Other: Placebo Drug
First Posted Date
2024-12-05
Last Posted Date
2024-12-05
Lead Sponsor
Marianna Mavromati
Target Recruit Count
60
Registration Number
NCT06717490
Locations
🇬🇷

Aretaieion University Hospital, Athens, Attica, Greece

Comparison Between Botox and Magnesium Sulfate Effect in Treatment of Myofascial Pain Trigger Points Within the Masseter Muscle

Phase 2
Not yet recruiting
Conditions
Myofacial Pain
Trigger Points, Myofascial
Interventions
Drug: BOTOX-A
Drug: Saline (NaCl 0,9 %) (placebo)
First Posted Date
2024-11-06
Last Posted Date
2024-11-11
Lead Sponsor
Misr University for Science and Technology
Target Recruit Count
60
Registration Number
NCT06676475
Locations
🇪🇬

Misr university for science and technology, GIza, Egypt

Evaluation of the Role of Magnesium in Prevention of AF Post Cardiac Surgery

Phase 3
Completed
Conditions
Atrial Fibrillation (AF)
Post Cardiac Surgery Patients
Magnesium Sulfate
Interventions
First Posted Date
2024-11-05
Last Posted Date
2025-05-06
Lead Sponsor
Ain Shams University
Target Recruit Count
130
Registration Number
NCT06675500
Locations
🇪🇬

Faculty of Medicine ,Ain Shams University, Cairo, Egypt

Intravenous Tramadol and Magnesium Sulphate for Prevention of Shivering

Phase 4
Not yet recruiting
Conditions
Lower Extremity Chronic Venous Ulcers
Varicose Veins Leg
Hernia
Interventions
First Posted Date
2024-09-25
Last Posted Date
2024-09-25
Lead Sponsor
Al-Azhar University
Target Recruit Count
180
Registration Number
NCT06612996

Lidocaine Versus Magnesium Sulphate in Management of Myofascial Pain Dysfunction Syndrome

Phase 2
Not yet recruiting
Conditions
Myofascial Pain Dysfunction Syndrome
Interventions
First Posted Date
2024-09-13
Last Posted Date
2024-09-19
Lead Sponsor
Misr University for Science and Technology
Target Recruit Count
75
Registration Number
NCT06595017

Efficacy of Iontophoresis in Treating Lateral Epicondylitis Patients

Phase 1
Recruiting
Conditions
Lateral Epicondylitis
Interventions
Other: conventional therapy
First Posted Date
2024-08-29
Last Posted Date
2024-08-29
Lead Sponsor
NOUR ALI ABO EL ELAA FRAGHLY
Target Recruit Count
40
Registration Number
NCT06578000
Locations
🇪🇬

Faculty of Physical Therapy, Cairo, Egypt

MgSO4 as Adjuvants to Bupivacaine vs Neostigmine in TAP Block in Cesarean Section

Phase 2
Not yet recruiting
Conditions
Cesarean Section
Interventions
Procedure: transversus abdominis plane (TAP) block in cesarean section
First Posted Date
2024-07-22
Last Posted Date
2024-07-22
Lead Sponsor
Assiut University
Target Recruit Count
68
Registration Number
NCT06513013

Magnesium Sulfate as an Adjunctive Analgesic in Prostate Surgery

Phase 4
Recruiting
Conditions
Prostatectomy
Interventions
First Posted Date
2024-06-27
Last Posted Date
2025-04-23
Lead Sponsor
NYU Langone Health
Target Recruit Count
110
Registration Number
NCT06477133
Locations
🇺🇸

NYU Langone Health, New York, New York, United States

Post-CA Neuroprotection With Magnesium

Phase 1
Recruiting
Conditions
Cardiac Arrest
Return of Spontaneous Circulation
Interventions
First Posted Date
2024-06-12
Last Posted Date
2025-05-22
Lead Sponsor
NYU Langone Health
Target Recruit Count
178
Registration Number
NCT06455514
Locations
🇺🇸

NYU Langone Health, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath